上海允麦生物科技有限公司

化工仪器网中级6

收藏

VHLH抗原,脑视网膜血管瘤G7蛋白抗原(逢希伯-林道氏病)

时间:2024-11-20      阅读:16

Recombinant human VHLH   

pVHL; pVHL; G7 protein; Elongin binding protein; HRCA 1; HRCA1; Protein G7; pVHL; RCA 1; RCA1; VHL 1; VHL; VHL_HUMAN; VHL1; VHLH; Von Hippel Lindau disease tumor suppressor; von Hippel Lindau syndrome; von Hippel Lindau tumor suppressor; Von Hippel-Lindau disease tumor suppressor.    

浓度:1mg/ ml

来源:Recombinant Human

纯度:≥95% SDS-PAGE

表达系统:Escherichia coli

标签:His tag

蛋白长度:Full length protein

内毒素水平:<1.000 Eu/µg

纯化方法:HPLC

应用:SDS-PAGE,Western blot,ELISA

Biological activity,immunology research

保存:-20℃

保质期:1年

Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases.



产品名称:Rabbit Anti-VHLH  antibody

Rabbit Anti-VHLH  

别名:pVHL; pVHL; G7 protein; Elongin binding protein; HRCA 1; HRCA1; Protein G7; pVHL; RCA 1; RCA1; VHL 1; VHL; VHL_HUMAN; VHL1; VHLH; Von Hippel Lindau disease tumor suppressor; von Hippel Lindau syndrome; von Hippel Lindau tumor suppressor; Von Hippel-Lindau disease tumor suppressor.        

来源:Rabbit

克隆类型:Polyclonal

浓度:1mg/ml

亚型:IgG

应用: WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500

反应:Human

免疫原:KLH conjugated synthetic peptide derived from human VHLH

保存:-20
保质期:1

 

单克隆抗体

产品名称:Anti-VHLH antibody

Mouse Anti-VHLH 

别名:pVHL; pVHL; G7 protein; Elongin binding protein; HRCA 1; HRCA1; Protein G7; pVHL; RCA 1; RCA1; VHL 1; VHL; VHL_HUMAN; VHL1; VHLH; Von Hippel Lindau disease tumor suppressor; von Hippel Lindau syndrome; von Hippel Lindau tumor suppressor; Von Hippel-Lindau disease tumor suppressor.     

来源:Mouse

克隆类型:Monoclonal

浓度:1mg/ml

亚型:IgG

应用: WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500

反应: Human

免疫原:KLH conjugated synthetic peptide derived from human VHLH

保存:-20
保质期:1

Involved in the ubiquitination and subsequent proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Seems to act as target recruitment subunit in the E3 ubiquitin ligase complex and recruits hydroxylated hypoxia-inducible factor (HIF) under normoxic conditions. Involved in transcriptional repression through interaction with HIF1A, HIF1AN and histone deacetylases.


上一篇: VHL抗原,脑视网膜血管瘤G7蛋白抗原(逢希伯-林道氏病) 下一篇: VGLUT2抗原,囊泡谷氨酸转运蛋白2抗原

下载此资料需要您留下相关信息

对本公司产品近期是否有采购需求?

提示

请选择您要拨打的电话: